KRAS and BRAF mutational status predicts the sensitivity of thyroid carcinoma cell lines to sunitinib.

Authors
Publication date
1 January 2011
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio Istituzionale della Ricerca- Università degli Studi di Foggia

    redirect
    oaioai:fair.unifg.it:11369/82720
    Last time updated on 03/09/2019